Note at the bottom of the publication:
Potential conflicts of Interest: The Tel Aviv Medical Center R&D Fund has received payment from the sponsor (PhytoTech Therapeutics) for the conduct of this study, through an agreement approved by the Israeli Ministry of Health. Dr. Jacob Atsmon, the Principal Investigator, is an employee of the Tel Aviv Medical Center.
Dr. Daphna Heffetz and Dr. Hagit Sacks are employees of Phytotech Therapuetics who funded the study.
Mr. Frederic Deutsch and Dr. Lisa Deutsch are the co-owner of BioStats Consulting Ltd. which was hired by the sponsor, Phytotech Therapuetics, to perform the statistical analyses of the study.
MMJ Price at posting:
43.5¢ Sentiment: Buy Disclosure: Held
